Sudeep Pharma
Sudeep Pharma Share Price Chart
Sudeep Pharma last traded at ₹1,020.70 (2026-10-13). Over the past month the stock moved -15.8%, three months the stock moved +46.4%. Its closing range over 52 weeks is ₹530.00 – ₹1,345.35, with the latest close 24.1% below the high.
Closing prices up to 2026-10-13.
About Sudeep Pharma
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.[1]
Company Overview[1] Sudeep Pharma Limited is a leading manufacturer of excipients and specialty ingredients catering to the pharmaceutical, food, and nutrition industries. The company has evolved from producing basic excipients to offering a broad portfolio of over 100 products, serving more than 1,100 customers globally. Its mineral-based ingredients, including calcium, zinc, iron, and magnesium salts, are widely used in formulations across health, nutrition, and food applications.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Sudeep Pharma reported sales of ₹158.00 crore (+26.4%) and net profit of ₹41.00 crore (+32.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 158.00 | 55.00 | 35.00 | 41.00 | 3.59 |
| Mar 2026 | 182.00 | 63.00 | 34.00 | 49.00 | 4.33 |
| Dec 2025 | 172.00 | 60.00 | 35.00 | 48.00 | 4.20 |
| Sep 2025 | 163.00 | 55.00 | 34.00 | 47.00 | 4.71 |
| Jun 2025 | 125.00 | 44.00 | 35.00 | 31.00 | 3.17 |
| Mar 2025 | 158.00 | 59.00 | 37.00 | 44.00 | 4.54 |
| Dec 2024 | 116.00 | 39.00 | 34.00 | 29.00 | 2.95 |
| Sep 2024 | 149.00 | 63.00 | 43.00 | 49.00 | 128.13 |
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales growth | +9.4% | +48.3% | +15.2% | +26.4% |
| Operating profit growth | -12.7% | +53.8% | +6.8% | +25.0% |
| Net profit growth | -4.1% | +65.5% | +11.4% | +32.3% |
| EPS growth | -96.3% | +42.4% | -4.6% | +13.2% |
| OPM % | 34.0% | 35.0% | 34.0% | 35.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Sudeep Pharma reported sales of ₹642.00 crore (+27.9%) and net profit of ₹174.00 crore (+25.2%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 642.00 | 222.00 | 35.00 | 174.00 | 15.31 |
| Mar 2025 | 502.00 | 191.00 | 38.00 | 139.00 | 14.27 |
| Mar 2024 | 459.00 | 182.00 | 40.00 | 133.00 | 945.36 |
| Mar 2023 | 429.00 | 90.00 | 21.00 | 62.00 | 442.27 |
| Mar 2022 | 343.00 | 67.00 | 20.00 | 50.00 | 356.04 |
| Mar 2021 | 215.00 | 44.00 | 20.00 | 33.00 | 236.60 |
| Mar 2020 | 123.00 | 25.00 | 21.00 | 18.00 | 128.02 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +74.8% | +59.5% | +25.1% | +7.0% | +9.4% | +27.9% |
| Operating profit growth | +76.0% | +52.3% | +34.3% | +102.2% | +4.9% | +16.2% |
| Net profit growth | +83.3% | +51.5% | +24.0% | +114.5% | +4.5% | +25.2% |
| EPS growth | +84.8% | +50.5% | +24.2% | +113.8% | -98.5% | +7.3% |
| OPM % | 20.0% | 20.0% | 21.0% | 40.0% | 38.0% | 35.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Sudeep Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Sudeep Pharma among 8 commodities stocks hitting 52-week highs; rallied up to 55% in a month - The Economic Times
-
Sudeep Pharma consolidated net profit rises 31.61% in the June 2026 quarter - Business Standard
-
Sudeep Pharma consolidated net profit rises 31.61% in the June 2026 quarter - Business Standard
Frequently Asked Questions
What is Sudeep Pharma's current stock price?
Sudeep Pharma shares were last quoted at ₹1,020.70 (-2.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Sudeep Pharma?
Sudeep Pharma has a price-to-earnings (P/E) ratio of 71.68 and a price-to-book (P/B) ratio of 14.17. The industry P/E is 53.33.
What is the 52-week high and low of Sudeep Pharma?
The 52-week high of Sudeep Pharma is ₹1,376.00 and the 52-week low is ₹524.95.
What is the market cap of Sudeep Pharma?
The market capitalisation of Sudeep Pharma is about ₹13,091.88 crore.
How did Sudeep Pharma perform in its latest quarterly results?
In the latest quarter (Jun 2026), Sudeep Pharma reported sales of ₹158.00 crore (+26.4%) and net profit of ₹41.00 crore (+32.3%), compared with the same quarter last year.
Is Sudeep Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Sudeep Pharma has a 3-year ROE of 32.00%, 3-year profit growth of 40.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Sudeep Pharma?
Promoters hold about 76.15% of Sudeep Pharma.
Which sector does Sudeep Pharma belong to?
Sudeep Pharma belongs to the Pharmaceuticals & Drugs sector.